Lyon’s Revolutionary Treatment
- LYON, France – The Civil Hospices of Lyon (HCL) have treated their 500th patient with CAR-T cell therapy, a form of immunotherapy used to treat blood cancers resistant...
- CAR-T cell therapy involves modifying a patient's own immune cells to target and destroy cancer cells.
- Researchers are exploring the potential of CAR-T therapy to treat solid tumors and autoimmune diseases in the future.
Lyon hospital Reaches Milestone with CAR-T Immunotherapy
Table of Contents
- Lyon hospital Reaches Milestone with CAR-T Immunotherapy
- CAR-T Cell Therapy: A Milestone in lyon, France – Your questions Answered
- What is CAR-T Cell Therapy?
- How Does CAR-T Cell Therapy Work?
- What Type of Cancer Does CAR-T Cell Therapy Treat?
- What is the Importance of the Lyon Hospital Milestone?
- What Makes Lyon Sud Hospital a Pioneer in CAR-T Therapy?
- What are the Potential Future Applications of CAR-T Cell Therapy?
- Where is the Treatment Being Offered?
- Are There Any Risks or Side Effects Associated with CAR-T Cell Therapy?
- key Takeaways – A Summary
- CAR-T Cell Therapy: A Milestone in lyon, France – Your questions Answered
LYON, France – The Civil Hospices of Lyon (HCL) have treated their 500th patient with CAR-T cell therapy, a form of immunotherapy used to treat blood cancers resistant to chemotherapy. The hematology department at Lyon Sud hospital, a pioneer in CAR-T therapy since 2018, recently reached this milestone.
CAR-T cell therapy involves modifying a patient’s own immune cells to target and destroy cancer cells. The Lyon Sud hospital has established a dedicated circuit for patients undergoing this treatment.
Researchers are exploring the potential of CAR-T therapy to treat solid tumors and autoimmune diseases in the future.
CAR-T Cell Therapy: A Milestone in lyon, France – Your questions Answered
this article explores the groundbreaking work in immunotherapy being done at the Civil Hospices of Lyon (HCL) in France, specifically focusing on CAR-T cell therapy. We’ll answer your key questions about this innovative treatment.
What is CAR-T Cell Therapy?
CAR-T cell therapy, short for Chimeric Antigen Receptor T-cell therapy, is a cutting-edge form of immunotherapy used to treat certain types of cancer. It involves modifying a patient’s own immune cells,specifically T-cells,to recognize and attack cancer cells.
How Does CAR-T Cell Therapy Work?
The process of CAR-T cell therapy usually involves the following steps:
- T-cell Collection: T-cells are extracted from the patient’s blood through a process called leukapheresis.
- Genetic Engineering: In a laboratory, the T-cells are modified. A special receptor called a chimeric Antigen Receptor (CAR) is added. This receptor is designed to recognize a specific protein on the surface of cancer cells.
- Cell expansion: The modified CAR-T cells are then grown in the laboratory to increase their numbers.
- Infusion: The expanded CAR-T cells are infused back into the patient’s body.
- Cancer Cell Destruction: Once inside the patient, the CAR-T cells seek out and bind to cancer cells, triggering their destruction.
What Type of Cancer Does CAR-T Cell Therapy Treat?
According to the source text, CAR-T cell therapy is currently used to treat blood cancers that haven’t responded to chemotherapy.
What is the Importance of the Lyon Hospital Milestone?
the Civil Hospices of Lyon (HCL), specifically the hematology department at Lyon Sud hospital, recently reached a significant achievement: treating their 500th patient with CAR-T cell therapy. This marks them as a pioneer in this field, with expertise dating back to 2018. This milestone signifies the hospital’s commitment to advanced cancer treatment and the increasing availability of this innovative therapy.
What Makes Lyon Sud Hospital a Pioneer in CAR-T Therapy?
Lyon Sud hospital has been a leader in CAR-T therapy since 2018. This early adoption, coupled with their achievement of treating 500 patients, highlights their deep experience and dedication to this advanced form of cancer treatment. The establishment of a “dedicated circuit” for patients undergoing CAR-T cell therapy further emphasizes their commitment to providing specialized care.
What are the Potential Future Applications of CAR-T Cell Therapy?
Researchers are actively investigating the potential of CAR-T cell therapy to treat:
Solid tumors (cancers that form solid masses or growths)
Autoimmune diseases (conditions where the immune system attacks the body’s own tissues).
Where is the Treatment Being Offered?
Based on the text, CAR-T cell therapy is being offered at the Lyon Sud hospital, part of the Civil Hospices of Lyon (HCL) in France.
Are There Any Risks or Side Effects Associated with CAR-T Cell Therapy?
While the provided text does not detail risks or side effects, it is indeed critically important to know that all medical treatments carry potential risks. CAR-T cell therapy can have side effects because it is an intensive treatment. Always consult with a qualified medical professional to discuss the risks and benefits as well as any associated side effects.
key Takeaways – A Summary
Here’s a speedy overview of CAR-T cell therapy:
| Feature | Description |
| ——————- | —————————————————————————————————————————– |
| What it is indeed | A type of immunotherapy that uses a patient’s own immune cells (T-cells) to fight cancer. |
| How it works | T-cells are modified to recognize and destroy cancer cells. |
| Current Use | Primarily for blood cancers resistant to chemotherapy. |
| future Potential | Research is focused on treating solid tumors and autoimmune diseases. |
| Lyon’s Role | Lyon Sud hospital (HCL) is a pioneer,reaching a milestone of 500 treated patients,demonstrating specialized care from 2018. |